X
Xiaorong Guo
Researcher at Harbin Medical University
Publications - 5
Citations - 110
Xiaorong Guo is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 4, co-authored 5 publications receiving 51 citations.
Papers
More filters
Journal ArticleDOI
MicroRNA-124: An emerging therapeutic target in cancer.
Xinqi Jia,Xu Wang,Xiaorong Guo,Jingjing Ji,Ge Lou,Junjie Zhao,Wenjia Zhou,Mian Guo,Maomao Zhang,Chao Li,Sheng Tai,Shan Yu +11 more
TL;DR: This review focuses on the specific molecular functions of miR‐124 and the downstream gene targets in major cancers, which provide preclinical evidence for the treatment of human cancer.
Journal ArticleDOI
Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics.
Shan Yu,Yanshuang Wu,Chunlong Li,Zhaowei Qu,Ge Lou,Xiaorong Guo,Jingjing Ji,Nan Li,Mian Guo,Maomao Zhang,Lei Lei,Sheng Tai +11 more
TL;DR: The expression profile, clinical application significance and prognostic value of the SLC16A family for patients with pancreatic cancer were explored, and their related genes and regulatory networks were identified, revealing core molecular pathways that require further investigation for pancreaticcancer.
Journal ArticleDOI
Fusobacterium nucleatum, the communication with colorectal cancer.
Kangjia Luo,Yvkun Zhang,Chao Xv,Jingjing Ji,Ge Lou,Xiaorong Guo,Meilun Chen,Yingjie Zhang,Huiying Wei,Mian Guo,Rui Huang,Shan Yu +11 more
TL;DR: Fusobacterium nucleatum (F.n), an anaerobe, is found to be enriched in both stools and tumor tissues of CRC patients and could be a biomarker of CRC.
Journal ArticleDOI
The multifaceted roles of long noncoding RNAs in pancreatic cancer: an update on what we know
Wenjia Zhou,Lu Chen,Chao Li,Rui Huang,Mian Guo,Shangwei Ning,Jingjing Ji,Xiaorong Guo,Ge Lou,Xinqi Jia,Junjie Zhao,Feng Luo,Chunlong Li,Zhaowei Qu,Shan Yu,Sheng Tai +15 more
TL;DR: The current understanding of the multifaceted roles of lncRNAs as regulators in the molecular mechanism of PC is addressed and the possibility of using lnc RNAs as survival biomarkers and their contributions to the development of targeted therapies based on the literature are discussed.
Journal ArticleDOI
SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma.
Hui Huang,Junwei Wang,Shibin Chen,HongJiang He,Yu Shang,Xiaorong Guo,Ge Lou,Jingjing Ji,Mian Guo,Hong Chen,Shan Yu +10 more
TL;DR: Wang et al. as mentioned in this paper investigated the SLC15A family members in lung cancer through accumulated data from TCGA and other available online databases by integrated bioinformatics analysis to reveal the prognostic value, potential clinical application and underlying molecular mechanisms of SLC 15A family member in lung Cancer.